Companies

Maze Therapeutics, Inc. (MAZE) SEC filings

CIK 0001842295 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025
Revenue (USD)167.5 M
Net income (USD)-131.1 M
Diluted EPS (USD/shares)-3.05

Latest filings

FiledFormDescriptionPeriod
2026-10-168-K8-K items 1.01,3.02,9.012026-10-15
2026-10-02442026-10-01
2026-10-02442026-10-01
2026-10-01144144
2026-10-01442026-09-29
2026-10-01144144
2026-09-08442026-09-04
2026-09-04144144
2026-09-04442026-09-02
2026-09-04442026-09-02
2026-09-04442026-09-02
2026-09-04442026-09-02
2026-09-03442026-09-01
2026-09-03442026-09-01
2026-09-03442026-09-01
2026-09-03442026-09-01
2026-09-02144144
2026-09-02144144
2026-09-02144144
2026-09-02144144
2026-09-01144144
2026-08-31442026-08-28
2026-08-17442026-08-13
2026-08-17442026-08-13
2026-08-17332026-08-13

Forms on file (last 1,000): 4 83, 144 24, 3 23, 8-K 16, SCHEDULE 13G/A 13, SCHEDULE 13G 11, CORRESP 6, UPLOAD 6. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=MAZE (0.002 USD), /gw/filings/filings?ticker=MAZE&form=8-K, /gw/filings/facts?ticker=MAZE&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange